Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment

Steve Seung-Young Lee1, Junjie Li1, Jien Nee Tai1

  • 1†Weldon School of Biomedical Engineering, ‡Department of Biological Sciences, §Department of Chemistry, ⊥Center for Cancer Research, ∥Department of Comparative Pathobiology, #Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.

ACS Nano
|February 10, 2015
PubMed

Insights

Targeting cholesterol metabolism with avasimin (avasimin) offers a novel cancer chemotherapy strategy. This approach selectively induces cancer cell death and suppresses tumor growth without harming healthy tissues.

Area of Science:

  • Oncology
  • Biochemistry
  • Nanotechnology

Background:

  • Cancer chemotherapy often causes undesirable side effects.
  • Altered cholesterol metabolism is a hallmark of cancer cells.
  • Acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) plays a role in cancer cell cholesterol homeostasis.

Purpose of the Study:

  • To develop a cancer-selective chemotherapy strategy by inhibiting ACAT-1.
  • To create a nanoformulation of avasimibe for targeted delivery to tumors.

Main Methods:

  • Developed a nanoformulation of avasimibe (avasimin) for systemic injection.
  • Tested avasimin in human cancer cell lines (prostate, pancreatic, lung, colon).
  • Evaluated avasimin efficacy and safety in prostate and colon cancer xenograft mouse models.

Main Results:

  • Avasimin reduced cholesteryl ester storage and increased free cholesterol in cancer cells, inducing apoptosis and inhibiting proliferation.
  • Intravenous avasimin administration achieved high drug concentrations in tumors.
  • Avasimin suppressed tumor growth and extended survival time in mice.
  • No adverse effects were observed in normal cells or organs.

Conclusions:

  • Targeting ACAT-1-mediated cholesterol esterification is a viable strategy for selective cancer chemotherapy.
  • Avasimin nanoformulation demonstrates potent anti-cancer effects with minimal toxicity.
  • This approach offers a promising new avenue for cancer treatment by exploiting cancer cell metabolic vulnerabilities.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.8K